Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid

Tumor‐derived cell‐free DNA (cfDNA) is an emerging biomarker for guiding the personalized treatment of patients with metastatic colorectal cancer (CRC). While patients with CRC liver metastases (CRC‐LM) have relatively high levels of plasma cfDNA, little is known about patients with CRC peritoneal m...

Descripción completa

Detalles Bibliográficos
Autores principales: van't Erve, Iris, Rovers, Koen P, Constantinides, Alexander, Bolhuis, Karen, Wassenaar, Emma CE, Lurvink, Robin J, Huysentruyt, Clément J, Snaebjornsson, Petur, Boerma, Djamila, van den Broek, Daan, Buffart, Tineke E, Lahaye, Max J, Aalbers, Arend GJ, Kok, Niels FM, Meijer, Gerrit A, Punt, Cornelis JA, Kranenburg, Onno, de Hingh, Ignace HJT, Fijneman, Remond JA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073000/
https://www.ncbi.nlm.nih.gov/pubmed/33635598
http://dx.doi.org/10.1002/cjp2.207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073000/
https://www.ncbi.nlm.nih.gov/pubmed/33635598
http://dx.doi.org/10.1002/cjp2.207

Ejemplares similares